These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Treatment of hypertension with bupranolol, bemetizide and triamterene]. Lederle RM; Klaus D Dtsch Med Wochenschr; 1982 Oct; 107(42):1587-91. PubMed ID: 7128471 [No Abstract] [Full Text] [Related]
9. [Urinary lithiasis due to triamterene]. Moesch C; Dumas JP; Leroux-Robert C Ann Urol (Paris); 1990; 24(1):17-9; discussion 20. PubMed ID: 2321916 [TBL] [Abstract][Full Text] [Related]
10. [Hypotensive effects of fursemide, triamterene and reserpine combination in patients with essential hypertension on ambulatory care]. Saldanha RV; Veras RO; de Paula e Silva P; de Serro-Azul LG Rev Paul Med; 1971 Nov; 78(4):137-40. PubMed ID: 5164638 [No Abstract] [Full Text] [Related]
11. The efficacy of a potassium-sparing combination of chlorthalidone and triamterene in the control of mild and moderate hypertension. I. Webb EL; Godfrey JC; Gertel A; Costello RJ; Applin WJ; Zisblatt M; Vukovich RA; Neiss ES J Int Med Res; 1984; 12(3):133-9. PubMed ID: 6376207 [TBL] [Abstract][Full Text] [Related]
12. The efficacy of a potassium-sparing combination of chlorthalidone and triamterene in the control of mild and moderate hypertension. II. Webb EL; Godfrey JC; Gertel A; Costello RJ; Cooper WH; Zisblatt M; Vukovich RA; Neiss ES J Int Med Res; 1984; 12(3):140-6. PubMed ID: 6376208 [TBL] [Abstract][Full Text] [Related]
13. Excretion of triamterene and its metabolite in triamterene stone patients. Ettinger B J Clin Pharmacol; 1985; 25(5):365-8. PubMed ID: 4031113 [TBL] [Abstract][Full Text] [Related]
14. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report. Hollenberg NK; Bannon JA Am J Med; 1986 Apr; 80(4A):30-6. PubMed ID: 3518430 [No Abstract] [Full Text] [Related]
15. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice. Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144 [No Abstract] [Full Text] [Related]
16. Potassium-sparing effects of triamterene in the treatment of hypertension. Spiekerman RE; Berge KG; Thurber DL; Gedge SW; McGuckin WF Circulation; 1966 Sep; 34(3):524-31. PubMed ID: 5332122 [No Abstract] [Full Text] [Related]